Financials

News Discussions Technicals Seasonals

NNG fundamentals

Overview Statements Statistics Dividends Earnings Revenue

Key facts

—

—

—

—

—

—

—

—

About

NanoGroup SA engages in the medical research and development. It develops diagnostic, therapeutic and rehabilitation tools for oncology patients. The company's projects include Nanovelos, NanoSanguis and NanoTHEA. NanoGroup was founded by Tomasz Adam Ciach on December 2, 2016 and is headquartered Warsaw, Poland.

Valuation

Fundamental metrics to determine fair value of the stock

Summary

No data available

There's currently no market capitalization, revenue or net income data to show.

Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends

NNG has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company